Klinger Shannon Thyme: insider trades.
Klinger Shannon Thyme reported 10 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($486K), across 1 company.
- Transactions
- 10
- Purchases (P)
- 0
- Sales (S)
- 1
- Companies
- 1
- Name as filed
- Klinger Shannon Thyme
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Moderna, Inc. (MRNA) | Officer · Chief Legal Officer | 10 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-04 | Moderna, Inc. | F | 5,704 | $148.87 | 81,340 | Form 4 |
| 2026-09-04 | Moderna, Inc. | M | 11,797 | — | 87,044 | Form 4 |
| 2026-09-01 | Moderna, Inc. | M | 2,166 | — | 76,295 | Form 4 |
| 2026-09-01 | Moderna, Inc. | F | 1,048 | $140.34 | 75,247 | Form 4 |
| 2026-09-01 | Moderna, Inc. | M | 3,471 | $30.96 | 77,600 | Form 4 |
| 2026-09-01 | Moderna, Inc. | S | 3,471 | $139.95 | 74,129 | Form 4 |
| 2026-08-28 | Moderna, Inc. | F | 160 | $142.77 | 74,129 | Form 4 |
| 2026-08-28 | Moderna, Inc. | M | 329 | — | 74,289 | Form 4 |
| 2026-08-27 | Moderna, Inc. | F | 375 | $149.66 | 73,960 | Form 4 |
| 2026-08-27 | Moderna, Inc. | M | 774 | — | 74,335 | Form 4 |
Questions
What stock did Klinger Shannon Thyme buy or sell?
Klinger Shannon Thyme reported 10 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 1 sale ($486K), across 1 company.
Is Klinger Shannon Thyme the same person as other filers with this name?
This page covers SEC CIK 1866132 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/klinger-shannon-thyme-1866132.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.